In lieu of the recent outbreak of the H7N9 bird flu that has infected 21 people (as of April 7), The China State Food and Drug Supervision Administration approved the use of an experimental antiviral drug called Peramivir on April 5.
The new drug is said to fight influenza virus, and has proven effective against the influenza A and B viruses (H7N9 belongs to the A group of influenza viruses).
China now joins the United States, Japan, and South Korea as one of the few countries to approve the use of Peramivir.
See also: Financial Times: Increase in Foreigners Leaving Beijing Due to “Airpocalypse”
Warning：The use of any news and articles published on eChinacities.com without written permission from eChinacities.com constitutes copyright infringement, and legal action can be taken.
Keywords: H7N9 bird flu Peramivir H7N9 drug
All comments are subject to moderation by eChinacities.com staff. Because we wish to encourage healthy and productive dialogue we ask that all comments remain polite, free of profanity or name calling, and relevant to the original post and subsequent discussion. Comments will not be deleted because of the viewpoints they express, only if the mode of expression itself is inappropriate.
Please login to add a comment. Click here to login immediately.
Sign up with
Google
